Comparison

PD-L1 Polyclonal Antibody

Item no. E-AB-60391-60
Manufacturer Elabscience
Amount 60 uL
Quantity options 120 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications IF
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
Citations https://www.sciencedirect.com/science/article/pii/S014486172100998X
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias B7-H, B7H1, PDL1, PD-L1, PDCD1L1, PDCD1LG1, CD274
Similar products CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, B7 homolog 1, CD274 molecule, PD-L1, MGC142294, MGC142296, CD274 antigen, B7-H1, PDCD1 ligand 1, Programmed death ligand 1, B7 H, B7 H1, B7H, CD 274, PD L1, PDL 1, RGD1566211, OTTHUMP00000021029, PD1L1
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
PD-L1
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight
20kDa/33kDa
Observed Molecular Weight
43kDa
Manufacturer - Research Areas
Cancer, Immunology
Background
This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.
Concentration
1mg/mL
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification Method
Affinity purification
Recommended Dilution
IF 1:50-1:200
Abbreviation
PD-L1
Clonality
Polyclonal
Immunogen
Recombinant fusion protein of human PD-L1 (NP_054862.1).
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 60 uL
Available: In stock
available

Delivery expected until 1/8/2026 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?